23
Aug
2010
27
Oct
2009
Posted in I - Series B, Q - 3Q09, R - INTERNATIONAL, X - Device (Cardiology), X - Device (Catheter)
Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.
07
Jul
2009
05
May
2009
Posted in I - Series F, Q - 2Q09, R - WEST, X - Device (Catheter), X - Opthalmology, XX - CA
iScience Interventional (Menlo Park, CA) a commercial-stage microcatheter device for the treatment of ocular diseases open-angle glaucoma and clinical-stage development focused on wet-AMD, closed a $20.5M Series F financing. Participants include Affinity Capital Management, Johnson & Johnson Development Corp., L Capital Partners, Clarian Health Ventures, Prism VentureWorks, Three Arch Ventures, DeNovo Ventures and Asset Management [...]
30
Mar
2009
Posted in I - Series C, Q - 1Q09, R - WEST, X - Cardiology, X - Device (Catheter), X - Renal, XX - CA
Ardian (Palo Alto, CA) a clinical-stage medical device company focused on catheter-based treatment for hypertension, chronic kidney disease and heart failure, closed a $47M Series C financing. Participants include Medtronic, Emergent Medical Partners, Advanced Technology Ventures, Morgenthaler Ventures and Split Rock Partners.
12
Jan
2009
04
Jan
2009
01
Dec
2008
30
Nov
2008
Posted in I - Series C, Q - 2Q08, R - MID WEST, X - Device (Catheter), X - Drug:Device Combo, X - Ischemia
CoAxia (Maple Grive, MN) development-stage medical device company focused on a catheter-based therapy for cerebral ischemia, closed a $11.5M Series C financing. Participants include Canaan Partners, Prism Venture Partners, Baird Venture Partners, Affinity Capital Management, Johnson and Johnson Development Corporation and SVB Capital Partners.
30
Nov
2008
Ekos Corp. (Bothell, WA) developer of drug delivery catheters leveraging ultrasound technology for peripheral arterial occlusions and administration of contrast media, closed a $5M Series C financing. Participants include ARCH Venture Partners, Bessemer Venture Partners, Merrill Lynch, Mitsui & Co., Spray Venture Partners, MedVenture Associates, Protostar, Technology Partners and Morgan Stanley Venture Partners.